Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing next-generation sulfur-based prodrugs for rare ...

The study shows that personalized medicine demands new competences that extend beyond traditional medical training.

Marica Vilcek shares her story in a new memoir, from her early life and escape from Czechoslovakia to her 30-year career at ...

The Supreme Court is debating the laws passed by more than half the states to bar transgender girls and women from playing on ...

Today’s lineup features a stark estimate of how Medicaid eligibility restrictions might lead to more cancer deaths, a look at ...

Doctors told The Post what "The Pitt" gets right and wrong — and how the show is impacting the "broken healthcare system." ...

"Under the right conditions, some dogs present behaviors strikingly similar to those of young children," lead scientist, Dr.

Gene therapy ‘switch’ may offer non-addictive pain relief. New approach targets pain signals while leaving the rest of the brain untouched.

In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...

Multimorbidity—when several chronic diseases occur at the same time—has become a growing barrier to effective healthcare.